UnitedHealthcare & Medtronic’s value-based care diabetes program improved outcomes in 1st year

Medtronic and Minnetonka, Minn.-based UnitedHealthcare partnered for a value-based program centered on improving outcomes for patients with diabetes, and initial results found the program improved outcomes and reduced hospital admissions, HIT Consultant reports.

Advertisement

Here’s what you should know:

1. The program provided Medtronic insulin pumps to UnitedHealthcare members with Type 1 diabetes. Researchers compared their outcomes to members who received multiple insulin injections daily.

2. More than 6,000 members received the pumps. After one year, patients with the pumps experienced a 27 percent decline in preventable hospital admissions compared to the injection group.

3. The results were the first of a multiyear initiative by UnitedHealthcare and Medtronic. The organizations will continue evaluating quality of care and cost.

4. With the success of the program, UnitedHealthcare continues pursuing value-based initiatives. By the end of 2020, UnitedHealthcare expects to have $75 billion in value-based contracts.

More articles on coding, billing and collections:
Will outpatient total joint replacement become the norm? Here’s how Dr. J. David Evanich has made it work
The key to successful spine cases in an ASC + key trends in outpatient spine: 4 questions with Dr. Gary P. Cram Jr.
5 common patient collections mistakes

Advertisement

Next Up in ASC Coding, Billing & Collections

Advertisement

Comments are closed.